Glycated hexapeptide oxidase and use thereof
The present invention provides a protein comprising an amino acid sequence in which arginine at position 61 of a protein comprising the amino acid sequence represented by SEQ ID NO: 1 is substituted to an amino acid selected from the group consisting of glycine, alanine, valine, leucine, serine, threonine, proline, cysteine, methionine, asparagine, glutamine, and aspartic acid; and a method for measuring a glycated hemoglobin in a sample, wherein the method comprises reacting a glycated hemoglobin in a sample with a protease to produce a glycated hexapeptide, then reacting the produced glycated hexapeptide with the aforementioned protein, and measuring a substance produced or consumed by the reaction.
1. An isolated protein comprising the amino acid sequence set forth in SEQ ID NO: 1 with a substitution of arginine at position 61 with an amino acid selected from the group consisting of glycine, alanine, valine, leucine, serine, threonine, proline, cysteine, methionine, asparagine, glutamine, and aspartic acid, wherein the isolated protein has glycated hexapeptide oxidase activity.
2. An isolated protein, wherein the protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:1, wherein the protein has glycated hexapeptide oxidase activity, and wherein the amino acid at position 61 is substituted with an amino acid selected from the group consisting of glycine, alanine, valine, leucine, serine, threonine, proline, cysteine, methionine, asparagine, glutamine, and aspartic acid.
3. The isolated protein of claim 1 , further having at least one mutation selected from the following (1) to (15) in the amino acid sequence set forth in SEQ ID NO: 1:
(1) mutation where arginine at position 63 is substituted with an amino acid selected from the group consisting of glycine, proline, and alanine;
(2) mutation where leucine at position 62 is substituted with glycine;
(3) mutation where glutamine at position 93 is substituted with glutamic acid;
(4) mutation where phenylalanine at position 267 is substituted with tyrosine;
(5) mutation where tyrosine at position 71 is substituted with serine or cysteine;
(6) mutation where aspartic acid at position 115 is substituted with an amino acid selected from the group consisting of asparagine and arginine;
(7) mutation where methionine at position 108 is substituted with an amino acid selected from the group consisting of lysine and arginine;
(8) mutation where leucine at position 75 is substituted with an amino acid selected from the group consisting of alanine and phenylalanine;
(9) mutation where serine at position 34 is substituted with threonine;
(10) mutation where tyrosine at position 52 is substituted with histidine;
(11) mutation where isoleucine at position 57 is substituted with valine;
(12) mutation where proline at position 66 is substituted with histidine;
(13) mutation where aspartic acid at position 95 is substituted with glutamic acid;
(14) mutation where lysine at position 105 is substituted with arginine; and
(15) mutation where alanine at position 355 is substituted with serine.
4. The isolated protein of claim 2 , further comprising an additional substitution, wherein the protein comprises an amino acid sequence that is at least 95% identical to any one of SEQ ID NOs: 3 to 37.
5. The isolated protein of claim 4 , wherein said protein comprises the amino acid sequence set forth in any one of SEQ ID NOs: 3 to 37.
6. The isolated protein of claim 2 , further comprising an additional substitution, wherein the protein comprises an amino acid sequence that is at least 95% identical to any one of SEQ ID NOs: 6 to 37, and wherein the protein has an activity of directly oxidizing glycated hemoglobin.
7. The isolated protein of claim 6 , wherein said protein comprises the amino acid sequence set forth in any one of SEQ ID NOs: 6 to 37.
8. The isolated protein of claim 6 , wherein the glycated hemoglobin is hemoglobin A1c.